Streetbeat News

Revenues

JILL

Four analysts have provided ratings for J.Jill (NYSE:JILL) in the latest quarter, showing a mix of bullish and bearish perspectives. The average 12-month price target is $42.25, with a high of $44.00 and a low of $37.00. This reflects an 11.18% increase from the previous average price target of $38.00. Analysts have highlighted J.Jill's strong financial performance, including a 7.5% revenue growth rate, a 10.34% net margin, a 36.97% ROE, and a 3.83% ROA. However, the company faces challenges with a high debt-to-equity ratio of 5.46.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 12:00 pm

BNS

KEY

KeyCorp (NYSE:KEY) shares are trading higher after announcing a strategic minority investment agreement with The Bank of Nova Scotia (NYSE:BNS). Scotiabank will invest approximately $2.8 billion in KeyCorp, acquiring about 14.9% of common stock at $17.17 per share. This investment is expected to boost KeyCorp’s CET1 capital ratio and tangible book value per share, and enhance profitability and capital strength. The initial purchase is expected to close by the end of August, with the additional purchase anticipated in the first quarter of 2025.

Portfolio Pulse from Lekha Gupta

August 12, 2024 | 11:59 am

PRZO

ParaZero shares are trading higher after the company received an order from a defense company for 50 drone safety systems intended for military operational use.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 11:54 am

PRZO

ParaZero Technologies Ltd. (NASDAQ:PRZO) has received an order from a leading Tier-One defense company for 50 drone safety systems for military operational use. The partnership aims to enhance the efficiency and safety of medical field mission deliveries, particularly in critical and remote areas.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 11:53 am

BTCUSD

A former Bank of Japan board member predicts that the central bank will delay further interest rate hikes until 2024, prioritizing market stability. This follows a significant rate hike in July, which impacted the Japanese yen and risk assets like Bitcoin.

Portfolio Pulse from Murtuza Merchant

August 12, 2024 | 11:33 am

AVTX

Avalo Therapeutics reported a Q2 2024 GAAP EPS of $(14.07), which is not comparable to the $(6.70) estimate. The company has approximately $93.4M in cash on hand as of June 30, 2024, with an expected cash runway into 2027.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 11:30 am

HE

Hawaiian Electric Industries shares are trading lower after reporting worse-than-expected Q2 adjusted EPS results and a year-over-year decrease in Q2 sales. Additionally, the company expects a $1.7 billion loss from the Maui fire pact.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 11:25 am

LXEO

Lexeo Therapeutics reported a Q2 2024 GAAP EPS of $(0.64), beating the estimate of $(0.69). The company has $175 million in cash and cash equivalents, expected to provide an operational runway into 2027.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 11:23 am

MPU

Mega Matrix Corp. (NYSE:MPU) announced that its short drama streaming platform, FlexTV, has ranked No.3 in the App Store Entertainment Chart and Google Play Entertainment App in Indonesia. This achievement highlights FlexTV's strong position in the Asian market and its growing global popularity.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 11:21 am

STIM

Neuronetics forecasts Q3 revenue of $18.5M-$19.5M, below the consensus of $20.115M. For 2024, the company expects sales of $78M-$80M, compared to the consensus of $79.15M. Full-year 2024 operating expenses are projected to be between $78M and $80M.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 11:18 am